Expression of matrix metalloproteinases-2, -8, -13, -26, and tissue inhibitors of metalloproteinase-1 in human osteosarcoma

Surgical Oncology

Volumn 20, Issue 1, 2011, Pages

  Korpi, Jarkko T ^a   Hagström, Jaana ^b   Lehtonen, Niko ^b   Parkkinen, Jyrki ^c   Sorsa, Timo ^b   Salo, Tuula ^d   Laitinen, Minna ^c  

^a OULU UNIVERSITY HOSPITAL   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c TAMPERE UNIVERSITY HOSPITAL   (Finland)

^d UNIVERSITY OF OULU   (Finland)

Author keywords

Bone tumour; Cancer; Matrix metalloproteinase; Survival

Indexed keywords

ANTINEOPLASTIC AGENT; COLLAGENASE 3; GELATINASE A; MATRIX METALLOPROTEINASE 26; NEUTROPHIL COLLAGENASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADOLESCENT; ADULT; AGED; CHILD; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOLOGY; MALE; METASTASIS; OSTEOSARCOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVIEW; SCHOOL CHILD; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC AGENTS; BONE NEOPLASMS; CHILD; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MATRIX METALLOPROTEINASES; MIDDLE AGED; OSTEOSARCOMA; PROGNOSIS; SURVIVAL ANALYSIS; TISSUE INHIBITOR OF METALLOPROTEINASE-1; YOUNG ADULT;

EID: 78650824229     PISSN: 09607404     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.suronc.2010.08.004     Document Type: Review

References (39)

1. M. Campanacci Bone and soft tissue tumors Bone and soft tissur tumors 2nd ed 1999 Springer-Verlag Padova
2. G. Saeter, T.A. Alvegard, I. Elomaa, A.E. Stenwig, T. Holmstrom, and O.P. Solheim Treatment of osteosarcoma of the extremities with the T-10 protocol, with emphasis on the effects of preoperative chemotherapy with single-agent high-dose methotrexate: a Scandinavian Sarcoma Group study J Clin Oncol 9 10 1991 Oct 1766 1775
3. G. Bacci, M. Mercuri, A. Longhi, S. Ferrari, F. Bertoni, and M. Versari Grade of chemotherapy-induced necrosis as a predictor of local and systemic control in 881 patients with non-metastatic osteosarcoma of the extremities treated with neoadjuvant chemotherapy in a single institution Eur J Cancer 41 14 2005 Sep 2079 2085
4. S. Smeland, C. Muller, T.A. Alvegard, T. Wiklund, T. Wiebe, and O. Bjork Scandinavian Sarcoma Group Osteosarcoma Study SSG VIII: prognostic factors for outcome and the role of replacement salvage chemotherapy for poor histological responders Eur J Cancer 39 4 2003 Mar 488 494 (Pubitemid 36173693)
5. N. Fuchs, S.S. Bielack, D. Epler, P. Bieling, G. Delling, and D. Korholz Long-term results of the co-operative German-Austrian-Swiss osteosarcoma study group's protocol COSS-86 of intensive multidrug chemotherapy and surgery for osteosarcoma of the limbs Ann Oncol 9 8 1998 Aug 893 899
6. J.A. Bramer, A.A. Abudu, R.M. Tillman, S.R. Carter, V.P. Sumathi, and R.J. Grimer Pre- and post-chemotherapy alkaline phosphatase levels as prognostic indicators in adults with localised osteosarcoma Eur J Cancer 41 18 2005 Dec 2846 2852
7. G.A. Ulaner, H.Y. Huang, J. Otero, Z. Zhao, L. Ben-Porat, and J.M. Satagopan Absence of a telomere maintenance mechanism as a favorable prognostic factor in patients with osteosarcoma Cancer Res 63 8 2003 Apr 15 1759 1763
8. E.E. Pakos, and J.P. Ioannidis The association of P-glycoprotein with response to chemotherapy and clinical outcome in patients with osteosarcoma. A meta-analysis Cancer 98 3 2003 Aug 1 581 589
9. X.S. Puente, L.M. Sanchez, C.M. Overall, and C. Lopez-Otin Human and mouse proteases: a comparative genomic approach Nat Rev Genet 4 7 2003 Jul 544 558
10. R. Visse, and H. Nagase Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry Circ Res 92 8 2003 May 2 827 839
11. M. Egeblad, and Z. Werb New functions for the matrix metalloproteinases in cancer progression Nat Rev Cancer 2 3 2002 Mar 161 174
12. H. Nagase, R. Visse, and G. Murphy Structure and function of matrix metalloproteinases and TIMPs Cardiovasc Res 69 3 2006 Feb 15 562 573
13. T. Sorsa, L. Tjaderhane, Y.T. Konttinen, A. Lauhio, T. Salo, and H.M. Lee Matrix metalloproteinases: contribution to pathogenesis, diagnosis and treatment of periodontal inflammation Ann Med 38 5 2006 306 321
14. P. Vihinen, and V.M. Kahari Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets Int J Cancer 99 2 2002 May 10 157 166
15. J.P. Witty, T. Lempka, R.J. Coffey Jr., and L.M. Matrisian Decreased tumor formation in 7,12-dimethylbenzanthracene-treated stromelysin-1 transgenic mice is associated with alterations in mammary epithelial cell apoptosis Cancer Res 55 7 1995 Apr 1 1401 1406
16. E. Kerkela, R. Ala-aho, P. Klemi, S. Grenman, S.D. Shapiro, and V.M. Kahari Metalloelastase (MMP-12) expression by tumour cells in squamous cell carcinoma of the vulva correlates with invasiveness, while that by macrophages predicts better outcome J Pathol 198 2 2002 Oct 258 269
17. D. Agarwal, S. Goodison, B. Nicholson, D. Tarin, and V. Urquidi Expression of matrix metalloproteinase 8 (MMP-8) and tyrosinase-related protein-1 (TYRP-1) correlates with the absence of metastasis in an isogenic human breast cancer model Differentiation 71 2 2003 Mar 114 125
18. M. Balbin, A. Fueyo, A.M. Tester, A.M. Pendas, A.S. Pitiot, and A. Astudillo Loss of collagenase-2 confers increased skin tumor susceptibility to male mice Nat Genet 35 3 2003 Nov 252 257
19. L.J. McCawley, H.C. Crawford, L.E. King Jr., J. Mudgett, and L.M. Matrisian A protective role for matrix metalloproteinase-3 in squamous cell carcinoma Cancer Res 64 19 2004 Oct 1 6965 6972
20. J. Decock, J.R. Long, R.C. Laxton, X.O. Shu, C. Hodgkinson, and W. Hendrickx Association of matrix metalloproteinase-8 gene variation with breast cancer prognosis Cancer Res 67 21 2007 Nov 1 10214 10221
21. J.T. Korpi, V. Kervinen, H. Maklin, A. Vaananen, M. Lahtinen, and E. Laara Collagenase-2 (matrix metalloproteinase-8) plays a protective role in tongue cancer Br J Cancer 98 4 2008 Feb 26 766 775
22. A.F. Foukas, N.S. Deshmukh, R.J. Grimer, D.C. Mangham, E.G. Mangos, and S. Taylor Stage-IIB osteosarcomas around the knee. A study of MMP-9 in surviving tumour cells J Bone Joint Surg Br 84 5 2002 Jul 706 711
23. B.P. Himelstein, N. Asada, M.R. Carlton, and M.H. Collins Matrix metalloproteinase-9 (MMP-9) expression in childhood osseous osteosarcoma Med Pediatr Oncol 31 6 1998 Dec 471 474
24. M. Uchibori, Y. Nishida, T. Nagasaka, Y. Yamada, K. Nakanishi, and N. Ishiguro Increased expression of membrane-type matrix metalloproteinase-1 is correlated with poor prognosis in patients with osteosarcoma Int J Oncol 28 1 2006 Jan 33 42
25. C. Ferrari, S. Benassi, F. Ponticelli, G. Gamberi, P. Ragazzini, and L. Pazzaglia Role of MMP-9 and its tissue inhibitor TIMP-1 in human osteosarcoma: findings in 42 patients followed for 1-16 years Acta Orthop Scand 75 4 2004 Aug 487 491
26. R. Hanemaaijer, T. Sorsa, Y.T. Konttinen, Y. Ding, M. Sutinen, and H. Visser Matrix metalloproteinase-8 is expressed in rheumatoid synovial fibroblasts and endothelial cells. Regulation by tumor necrosis factor-alpha and doxycycline J Biol Chem 272 50 1997 Dec 12 31504 31509
27. J.A. Uria, and C. Lopez-Otin Matrilysin-2, a new matrix metalloproteinase expressed in human tumors and showing the minimal domain organization required for secretion, latency, and activity Cancer Res 60 17 2000 Sep 1 4745 4751
28. A.M. Davis, R.S. Bell, and P.J. Goodwin Prognostic factors in osteosarcoma: a critical review J Clin Oncol 12 2 1994 Feb 423 431
29. K. Bjornland, K. Flatmark, S. Pettersen, A.O. Aaasen, O. Fodstad, and G.M. Maelandsmo Matrix metalloproteinases participate in osteosarcoma invasion J Surg Res 127 2 2005 Aug 151 156
30. J. Ma, U. Kitti, O. Teronen, T. Sorsa, V. Husa, and P. Laine Collagenases in different categories of peri-implant vertical bone loss J Dent Res 79 11 2000 Nov 1870 1873
31. J.T. Korpi, P. Astrom, N. Lehtonen, L. Tjaderhane, S. Kallio-Pulkkinen, and M. Siponen Healing of extraction sockets in collagenase-2 (matrix metalloproteinase-8)-deficient mice Eur J Oral Sci 117 3 2009 Jun 248 254
32. P. Henle, G. Zimmermann, and S. Weiss Matrix metalloproteinases and failed fracture healing Bone 37 6 2005 Dec 791 798
33. W.F. Grigioni, A. D'Errico, M. Fiorentino, P. Baccarini, M. Onisto, and C. Caenazzo Gelatinase A (MMP-2) and its mRNA detected in both neoplastic and stromal cells of tumors with different invasive and metastatic properties Diagn Mol Pathol 3 3 1994 Sep 163 169
34. M. Takahashi, N. Oka, T. Naroda, M.A. Nishitani, K. Kanda, and H.O. Kanayama Prognostic significance of matrix metalloproteinases-2 activation ratio in renal cell carcinoma Int J Urol 9 10 2002 Oct 531 538
35. L.O. Gonzalez, M.D. Corte, J. Vazquez, S. Junquera, R. Sanchez, and A. Vina Study of matrix metalloproteinases and their tissue inhibitors in ductal in situ carcinomas of the breast Histopathology 53 4 2008 Oct 403 415
36. A. Westerlund, M. Apaja-Sarkkinen, M. Hoyhtya, U. Puistola, and T. Turpeenniemi-Hujanen Gelatinase A-immunoreactive protein in ovarian lesions -prognostic value in epithelial ovarian cancer Gynecol Oncol 75 1 1999 Oct 91 98
37. A. Vaisanen, M. Kallioinen, K. von Dickhoff, L. Laatikainen, M. Hoyhtya, and T. Turpeenniemi-Hujanen Matrix metalloproteinase-2 (MMP-2) immunoreactive protein -a new prognostic marker in uveal melanoma? J Pathol 188 1 1999 May 56 62
38. M.S. Benassi, G. Gamberi, G. Magagnoli, L. Molendini, P. Ragazzini, and M. Merli Metalloproteinase expression and prognosis in soft tissue sarcomas Ann Oncol 12 1 2001 Jan 75 80
39. S. Govender, C. Csimma, H.K. Genant, A. Valentin-Opran, Y. Amit, and R. Arbel Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients J Bone Joint Surg Am 84-A 12 2002 Dec 2123 2134